BRPI1013380A2 - derivados de compostos de [3,2-c]pirazol esteroides com atividade glicocorticoide - Google Patents

derivados de compostos de [3,2-c]pirazol esteroides com atividade glicocorticoide

Info

Publication number: BRPI1013380A2
Authority: BR; Brazil
Prior art keywords: steroidal; derivatives; pyrazole compounds; glucocorticoid activity; glucocorticoid
Prior art date: 2009-04-03

Application number

BRPI1013380A

Other languages

English (en)

Inventor

Balint Gabos

Frank Burkamp

Hakan Bladh

Peter Robert Hansen

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-04-03

Filing date

2010-04-01

Publication date

2016-03-29

2010-04-01 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2016-03-29 Publication of BRPI1013380A2 publication Critical patent/BRPI1013380A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0042—Nitrogen only
- C07J71/0047—Nitrogen only at position 2(3)

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Oncology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Communicable Diseases (AREA)
Hematology (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Obesity (AREA)
Orthopedic Medicine & Surgery (AREA)
Emergency Medicine (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Ophthalmology & Optometry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Physical Education & Sports Medicine (AREA)
Reproductive Health (AREA)
Otolaryngology (AREA)
Transplantation (AREA)

BRPI1013380A 2009-04-03 2010-04-01 derivados de compostos de [3,2-c]pirazol esteroides com atividade glicocorticoide BRPI1013380A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US16632509P	2009-04-03	2009-04-03
PCT/SE2010/050367 WO2010114476A1 (en)	2009-04-03	2010-04-01	Novel derivatives of steroidal[3,2-c]pyrazole compounds with glucocorticoid activity

Publications (1)

Publication Number	Publication Date
BRPI1013380A2 true BRPI1013380A2 (pt)	2016-03-29

Family

ID=42826695

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1013380A BRPI1013380A2 (pt)	2009-04-03	2010-04-01	derivados de compostos de [3,2-c]pirazol esteroides com atividade glicocorticoide

Country Status (28)

Country	Link
US (1)	US8338587B2 (pt)
EP (1)	EP2414377B1 (pt)
JP (1)	JP5739868B2 (pt)
KR (1)	KR101599574B1 (pt)
CN (1)	CN102459305B (pt)
AR (1)	AR076036A1 (pt)
AU (1)	AU2010233020B2 (pt)
BR (1)	BRPI1013380A2 (pt)
CA (1)	CA2757424A1 (pt)
CL (1)	CL2011002463A1 (pt)
CO (1)	CO6420349A2 (pt)
CR (1)	CR20110519A (pt)
CU (1)	CU20110185A7 (pt)
DO (1)	DOP2011000304A (pt)
EA (1)	EA021342B1 (pt)
EC (1)	ECSP11011369A (pt)
ES (1)	ES2568665T3 (pt)
HN (1)	HN2011002578A (pt)
IL (1)	IL214982A0 (pt)
MX (1)	MX2011010208A (pt)
NI (1)	NI201100176A (pt)
PE (1)	PE20120644A1 (pt)
SG (1)	SG174249A1 (pt)
TW (1)	TWI472533B (pt)
UA (1)	UA105920C2 (pt)
UY (1)	UY32520A (pt)
WO (1)	WO2010114476A1 (pt)
ZA (1)	ZA201108049B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ584160A (en) *	2007-10-04	2011-05-27	Astrazeneca Ab	Steroidal [3,2-c] pyrazole compounds, with glucocorticoid activity
RU2010124799A (ru) *	2007-12-20	2012-01-27	Астразенека Аб (Se)	Производные стероидов, действующие в качестве агонистов глюкокортикостероидных рецепторов
UY32525A (es) *	2009-04-03	2010-10-29	Astrazeneca Ab	Compuestos que tienen actividad agonista del receptor de glucocorticosteroides
UY32523A (es) *	2009-04-03	2010-10-29	Astrazeneca Ab	Compuestos que tienen actividad agonista del receptor de glucocorticosteroides
UY32521A (es) *	2009-04-03	2010-10-29	Astrazeneca Ab	Combinación para emplear en el tratamiento de enfermedades respiratorias
GB201016912D0 (en)	2010-10-07	2010-11-24	Astrazeneca Ab	Novel combination
CN104402964B (zh) *	2014-12-10	2016-06-15	南京大学	闭花木酮的o-(咪唑基)乙基衍生物、制备方法及其用途
CN104744556B (zh) *	2015-04-15	2016-06-29	马修尧	闭花木酮的o-(1h-四氮唑基)乙基衍生物、制备方法及其用途
KR102497070B1 (ko)	2016-10-14	2023-02-06	반 안델 리서치 인스티튜트	고효능 글루코코르티코이드의 설계를 위한 구조 및 메커니즘

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE585432A (fr)	1958-12-08	1960-06-08	American Cyanamid Co	Stéroïdes fluorés.
US3129218A (en)	1961-11-01	1964-04-14	Merck & Co Inc	2-alkoxymethylene steroids of the androstane and pregnane series
US3072639A (en)	1962-03-05	1963-01-08	Merck & Co Inc	16-oxygenated-4-pregneno-[3, 2-c] pyrazoles and process of preparing them
US3129281A (en) *	1962-09-25	1964-04-14	George W Hardin	Electric fence insulator and post
US3364203A (en)	1965-09-09	1968-01-16	Syntex Corp	6, 7-methylene and 6, 7-halomethylene pyrazole pregnanes and processes for their preparation
US3471477A (en)	1967-10-18	1969-10-07	Syntex Corp	6-gem-difluoro (3,2-c) and (2,3-d) pyrazole steroids
DE2727367A1 (de)	1977-06-14	1979-01-04	Schering Ag	Neue kortikoide
DE2735110A1 (de)	1977-08-04	1979-02-15	Hoechst Ag	Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung
DE2817988A1 (de)	1978-04-25	1979-11-08	Hoechst Ag	Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
JPS6067495A (ja)	1983-09-22	1985-04-17	Ota Seiyaku Kk	ピラゾール誘導体
SE8306370D0 (sv)	1983-11-18	1983-11-18	Draco Ab	Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
WO1994025478A1 (en)	1993-04-29	1994-11-10	Instytut Farmaceutyczny	16α,17α-ACETAL GLUCOCORTICOSTEROIDAL DERIVATIVES
GB9624482D0 (en)	1995-12-18	1997-01-15	Zeneca Phaema S A	Chemical compounds
NZ330868A (en)	1996-02-13	2000-01-28	Zeneca Ltd	4-phenoxy, phenylthio or phenylamino substituted quinazoline derivatives ane medicaments useful as VEGF inhibitors
ES2169355T3 (es)	1996-03-05	2002-07-01	Astrazeneca Ab	Derivados de 4-anilinoquinazolina.
GB9718972D0 (en)	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
GB9714249D0 (en)	1997-07-08	1997-09-10	Angiogene Pharm Ltd	Vascular damaging agents
GB9900334D0 (en)	1999-01-07	1999-02-24	Angiogene Pharm Ltd	Tricylic vascular damaging agents
GB9900752D0 (en)	1999-01-15	1999-03-03	Angiogene Pharm Ltd	Benzimidazole vascular damaging agents
CA2406979A1 (en)	2000-05-31	2001-12-06	Astrazeneca Ab	Indole derivatives with vascular damaging activity
CA2411160A1 (en)	2000-07-07	2002-01-17	Angiogene Pharmaceuticals Limited	Colchinol derivatives as vascular damaging agents
EE200300015A (et)	2000-07-07	2004-10-15	Angiogene Pharmaceuticals Limited	Kolhinooli derivaadid kui angiogeneesi inhibiitorid
GB0110411D0 (en)	2001-04-27	2001-06-20	Astrazeneca Ab	Chemical process
AR033290A1 (es) *	2001-04-30	2003-12-10	Glaxo Group Ltd	Derivados antiinflamatorios de androstano
ITMI20022606A1 (it)	2002-12-09	2004-06-10	Farmabios Spa	Processo di sintesi di steroidi polialogenati.
WO2005028495A1 (en)	2003-09-24	2005-03-31	Glaxo Group Limited	Anti-inflammatory glucocorticoids
WO2005063777A1 (en)	2003-12-23	2005-07-14	Corus Pharma	Benzylphosphate and substituted benzylphosphate prodrugs for the treatment of pulmonary inflammation
GB0507165D0 (en)	2005-04-08	2005-05-18	Glaxo Group Ltd	Novel crystalline pharmaceutical product
WO2007054974A2 (en)	2005-09-28	2007-05-18	Arch Pharmalab Limited	A green chemistry process for the preparation of pregnadiene esters
NZ584160A (en)	2007-10-04	2011-05-27	Astrazeneca Ab	Steroidal [3,2-c] pyrazole compounds, with glucocorticoid activity
RU2010124799A (ru)	2007-12-20	2012-01-27	Астразенека Аб (Se)	Производные стероидов, действующие в качестве агонистов глюкокортикостероидных рецепторов
JP2011507879A (ja)	2007-12-21	2011-03-10	シェーリングコーポレイション	グルココルチコイド受容体アゴニストとしてのｃ−２１チオエーテル
JP2011513303A (ja)	2008-02-27	2011-04-28	アストラゼネカ・アクチエボラーグ	１６アルファ，１７アルファ−アセタールグルココルチコステロイド誘導体およびその使用
UY32521A (es)	2009-04-03	2010-10-29	Astrazeneca Ab	Combinación para emplear en el tratamiento de enfermedades respiratorias
UY32525A (es)	2009-04-03	2010-10-29	Astrazeneca Ab	Compuestos que tienen actividad agonista del receptor de glucocorticosteroides
UY32523A (es)	2009-04-03	2010-10-29	Astrazeneca Ab	Compuestos que tienen actividad agonista del receptor de glucocorticosteroides

2010
- 2010-03-26 UY UY0001032520A patent/UY32520A/es not_active Application Discontinuation
- 2010-03-30 US US12/749,911 patent/US8338587B2/en not_active Expired - Fee Related
- 2010-03-31 AR ARP100101086A patent/AR076036A1/es unknown
- 2010-04-01 EA EA201190236A patent/EA021342B1/ru not_active IP Right Cessation
- 2010-04-01 KR KR1020117023085A patent/KR101599574B1/ko not_active IP Right Cessation
- 2010-04-01 UA UAA201110628A patent/UA105920C2/uk unknown
- 2010-04-01 PE PE2011001758A patent/PE20120644A1/es not_active Application Discontinuation
- 2010-04-01 BR BRPI1013380A patent/BRPI1013380A2/pt not_active IP Right Cessation
- 2010-04-01 EP EP10759128.1A patent/EP2414377B1/en active Active
- 2010-04-01 JP JP2012503375A patent/JP5739868B2/ja not_active Expired - Fee Related
- 2010-04-01 WO PCT/SE2010/050367 patent/WO2010114476A1/en active Application Filing
- 2010-04-01 SG SG2011063757A patent/SG174249A1/en unknown
- 2010-04-01 CN CN201080024580.8A patent/CN102459305B/zh not_active Expired - Fee Related
- 2010-04-01 AU AU2010233020A patent/AU2010233020B2/en not_active Ceased
- 2010-04-01 CA CA2757424A patent/CA2757424A1/en not_active Abandoned
- 2010-04-01 MX MX2011010208A patent/MX2011010208A/es not_active Application Discontinuation
- 2010-04-01 ES ES10759128.1T patent/ES2568665T3/es active Active
- 2010-04-02 TW TW99110332A patent/TWI472533B/zh not_active IP Right Cessation
2011
- 2011-09-05 IL IL214982A patent/IL214982A0/en unknown
- 2011-09-08 CO CO11116286A patent/CO6420349A2/es not_active Application Discontinuation
- 2011-09-30 HN HN2011002578A patent/HN2011002578A/es unknown
- 2011-10-03 CU CU20110185A patent/CU20110185A7/es unknown
- 2011-10-03 CL CL2011002463A patent/CL2011002463A1/es unknown
- 2011-10-03 DO DO2011000304A patent/DOP2011000304A/es unknown
- 2011-10-03 CR CR20110519A patent/CR20110519A/es unknown
- 2011-10-03 NI NI201100176A patent/NI201100176A/es unknown
- 2011-10-03 EC EC2011011369A patent/ECSP11011369A/es unknown
- 2011-11-02 ZA ZA2011/08049A patent/ZA201108049B/en unknown

Also Published As

Publication number	Publication date
SG174249A1 (en)	2011-10-28
IL214982A0 (en)	2011-11-30
CN102459305B (zh)	2015-03-25
MX2011010208A (es)	2011-10-14
AU2010233020A1 (en)	2011-10-20
AR076036A1 (es)	2011-05-11
JP5739868B2 (ja)	2015-06-24
ZA201108049B (en)	2014-08-27
EP2414377A1 (en)	2012-02-08
CL2011002463A1 (es)	2012-04-09
EA021342B1 (ru)	2015-05-29
TWI472533B (zh)	2015-02-11
ECSP11011369A (es)	2011-11-30
UA105920C2 (uk)	2014-07-10
WO2010114476A1 (en)	2010-10-07
US8338587B2 (en)	2012-12-25
EA201190236A1 (ru)	2012-04-30
AU2010233020B2 (en)	2012-11-15
NI201100176A (es)	2012-06-14
US20100256103A1 (en)	2010-10-07
HN2011002578A (es)	2014-09-29
JP2012522768A (ja)	2012-09-27
KR101599574B1 (ko)	2016-03-04
CR20110519A (es)	2011-11-07
PE20120644A1 (es)	2012-06-24
EP2414377A4 (en)	2012-09-19
CU20110185A7 (es)	2012-02-15
DOP2011000304A (es)	2011-10-31
CA2757424A1 (en)	2010-10-07
KR20120002984A (ko)	2012-01-09
EP2414377B1 (en)	2016-01-06
TW201040197A (en)	2010-11-16
CN102459305A (zh)	2012-05-16
CO6420349A2 (es)	2012-04-16
ES2568665T3 (es)	2016-05-03
UY32520A (es)	2010-10-29

Publication	Publication Date	Title
BRPI0817941A2 (pt)	2015-05-05	Compostos de pirazol de [3,2-c] esteroidais, com atividade glucocorticóide
BRPI1013380A2 (pt)	2016-03-29	derivados de compostos de [3,2-c]pirazol esteroides com atividade glicocorticoide
ZA201108050B (en)	2014-04-30	Novel amide derivatives of steroidal[3,2-c]pyrazole compounds with glucocorticoid activity
BR112012000769A2 (pt)	2016-02-23	lupeol -tipo de derivados triterpenos como antivirais
BRPI1009118A2 (pt)	2016-12-06	3h-imidazo[4,5-c] piridina-6-carboxamidas como agentes anti-inflamatórios
IL221132A0 (en)	2012-09-24	Derivatives of betulin
BRPI0919738A2 (pt)	2015-12-08	3h-imidazo[4,5-c] piridino-6-carboxamidas como agentes anti-inflamatórios
ZA201203615B (en)	2015-03-25	Derivatives of 1-amino-2-cyclobutylethylboronic acid
BRPI0817562A2 (pt)	2017-05-02	derivados de n-hidroxilsulfonamida como novos doadores de niltroxil fisiologicamente úteis
EP2331089A4 (en)	2011-12-21	USES OF SESQUITERPENE DERIVATIVES
BRPI1012857A2 (pt)	2019-09-24	derivados de ciclopenta[c]pirrol-2-carboxilatos, o respectivo preparo e a respectiva aplicação em terapêutica
BRPI1013853A2 (pt)	2019-09-24	composições tópicas estáveis de derivados de 1,2,4-tiadiazol
BRPI0816806A2 (pt)	2015-03-10	Derivados de azaciclil-isoquinolinona e isoindolinona como antagonista de histamina-3
SI2260029T1 (sl)	2015-01-30	Priprava morfolinskih derivatov
CU23857B1 (es)	2013-02-26	Nuevos derivados de benzamida como antagonistas de la bradiquinina
EP2242493A4 (en)	2011-09-07	Gefitinib DERIVATIVES
BR112012016923A2 (pt)	2015-09-01	Derivados de pirazol
EP2411009B8 (fr)	2013-06-26	Applications thérapeutiques de dérivés de quinazolinedione
EP2231687A4 (en)	2012-11-14	NEW DERIVATIVES OF ACYL-CYANPYRROLIDINES
GB0624963D0 (en)	2007-01-24	Derivatives of 188-Glycyrrhetinic Acid
BR112012014770A2 (pt)	2016-03-29	derivados de etinila
CU23884B1 (es)	2013-04-19	Derivados de dibenzotiazepina
IL218500A0 (en)	2012-07-31	Apogossypolone derivatives as anticaner agents
CU23864B1 (es)	2013-03-27	Nuevos derivados no peptídicos como antagonistas b1 de la bradiquinina
IL207557A0 (en)	2010-12-30	Process for the preparation of pregnane derivatives

Legal Events

Date	Code	Title
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-01-30	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2018-05-22	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]